Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Emergency Contraception |
Dose: Tablet – 30 mg Frequency: once Note: Take orally as soon as possible within 120 hours (5 days) after unprotected intercourse or a known or suspected contraceptive failure; if vomiting occurs within 3 hours of intake, consideration should be given to repeating the dose; if a dose is missed, take as soon as possible, but if missed by greater than 12 hours, skip the missed dose. |
|
Indication: Uterine Fibroids |
Dose: Tablet – 5 mg Frequency: once daily Duration: up to 3 months Note: Treatment should always be started during the 1st week of menstruation; this 3-month treatment course can be repeated once; re-treatment should start at the earliest during the second menstruation following the 1st treatment course completion; if a dose is missed, take as soon as possible, but if missed by greater than 12 hours, skip the missed dose and resume usual schedule. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Emergency contraception Age: Females of reproductive age |
Dose: Oral – 30 mg Frequency: Single dose Note: as soon as possible within 120 hours (5 days) after unprotected intercourse or known or suspected contraceptive failure; by mouth (oral) |
Administration
- Can be taken with or without food
- Take as soon as possible after unprotected intercourse
Side Effect
- Mood disorders
- headache
- dizziness
- nausea
- abdominal pain/discomfort
- vomiting
- myalgia
- back pain
- dysmenorrhea
- pelvic pain
- breast tenderness
- fatigue
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Medicinal products containing progestagen
|
Not recommended
|
|
Potent CYP3A4 inducers (e.g. rifampicin, rifabutin, carbamazepine, oxcarbazepine, phenytoin, fosphenytoin, phenobarbital, primidone, St John's wort, efzvirenz, nevirapine, long term use of ritonavir)
|
Not recommended
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Genital Bleeding of Unknown Aetiology
|
Risk of masking underlying serious conditions
|
|
Uterine Cancer, Cervical Cancer, Ovarian Cancer, Breast Cancer
|
May worsen hormone-sensitive cancers
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a dry and cool place, protected from sunlight. Do not freeze. Keep out of reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.